近年来,哮喘的现患率一直在增加,已成为世界上最常见的慢性病之一。但是,现有的治疗仍不能完全控制许多患者的哮喘症状,研究表明白三烯在哮喘中起着重要作用,抗白三烯药物为目前的治疗提供了新的选择。为此,我们在临床上观察了白三烯受体拮抗剂——安可来控制支气管哮喘方面的疗效及毒副作用。 1 对象与方法 In recent years, the prevalence of asthma has been rising and has become one of the most common chronic diseases in the world. However, the current treatment still can not completely control asthma symptoms in many patients. Studies have shown that leukotrienes play an important role in asthma. Anti-leukotriene drugs provide a new option for the current treatment. To this end, we observed clinically leukotriene receptor antagonist - Encore to control the efficacy and side effects of bronchial asthma. 1 objects and methods